The #PBPS is excited to introduce the next President, @MichelleReidMD of @EmoryPathology Congratulations, Dr. Reid and best wishes for a successful term!
We also thank @OlcaBasturk for her leadership of #PBPS & taking it to new heights over the last 2 years!
The immunomodulatory subtype showed greater sensitivity to gemcitabine/cisplatin, while TNK1 was identified as a potential therapeutic target in the metabolic subtype and validated in PDX models.
1
1
32
Integrated multiomic profiling combined with machine learning identified three molecular subtypes of cholangiocarcinoma:
1. Immunomodulatory
2. Metabolic
3. Gene regulation/cell-fate
1
1
31
Spotlight article for August-October 2026: Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target.
Mun DG, ... Smoot RL. Hepatology. 2026. pubmed.ncbi.nlm.nih.gov/4102…
It's that time again! The PBPS Journal Watch for August 2026 - October 2026 is out. Log in to download, read, and track new articles in pancreatobiliary pathology.
link: pbpath.org/current-journal-w…
Letter from #PBPS President Dr. Huamin Wang on Pancreatic Cancer Awareness Month. Sharing with our members and friends on the importance of awareness, collaboration, and our collective commitment to improving care for patients with pancreatic cancer.
Join #PBPS for our Companion Society Session at the 2026 ASCP & CAP-ACP Joint Annual Meeting in Montréal, Canada: “Gallbladder & Biliary Pathology: Avoiding Diagnostic Pitfalls and Recognizing What Matters.” #PathTwitter
Date: Fri, Nov 20
Time: 2:30–3:30 PM
Location: 520F
Wonderful moments from the IAP Turkish Division Annual Meeting 2026 in Istanbul, Türkiye. We are pleased to share some highlights celebrating scientific exchange, friendship, and collaborations. #PBPS #PathTwitter
November is #PancreaticCancerAwarenessMonth! 💜
Together, let’s raise awareness, support patients and families, and advance research toward better treatments.
On Nov 19, wear purple for #WorldPancreaticCancerDay and help spread the word!
pancreatic.org/november/
📢 Registration Reminder!
Join #PBPS and #USCAP for our Interactive Microscopy Course, Unlocking Pancreatobiliary Pathology, February 3–5, 2027, in Palm Springs, CA!
🔗 Register: my.uscap.org/uscap/program/O…
PBPS companion meeting at The XXXVI International Congress of the International Academy of Pathology (IAP), photos courtesy of dear PBPS president, Dr.Huamin Wang. @Huaminwang6 @MichelleReidMD @navale_pooja @OlcaBasturk @Mvgs1706 @AgostiniVulajDO @VidyaArole @dianachenfd
Thanks to the authors of this case: Byoung Uk Park, MD, and David Marshall Cartwright, MD, from the University of Minnesota Pathology!
1
99
The new case of the quarter is live! "When Cyst Fluid Misleads: A Mucinous Cyst Mimic in the Pancreatic Tail" PBPS members, please check out the case and join the discussion. Log in to view and comment:
pbpath.org/case-5-quarter-4-…
In 6 reported cases, all showed papillary architecture, diffuse squamous differentiation, high-grade dysplasia, and associated invasive carcinoma, supporting IPSN as a distinct entity alongside IPMN, IOPN, and ITPN. @Michellereidmd @Olcabasturk @cui_min_GI_path @b_histopath
#Pancreas cancer update: New pancreatic precursor lesion may be entering the canon: IPSN.
pubmed.ncbi.nlm.nih.gov/4212…
@Michellereidmd @Olcabasturk @agostinivulajDO @Mvgs1706 @Navale_pooja @DianaChenfd @CLuchini10 @HuaminWang6 @raulsgonzalezMD @MengxuePath @bekirMD @cui_min_GI_path






















